Mou, T.C., Gille, A., Fancy, DA, Seifert, R and Sprang, S.R., (2005) “Structural basis for the inhibition of mammalian adenylyl cyclase by 2’(3’)-O-(N-methylanthraniolyl)-guanosine 5’-triphosphate” Journal of Biololgical Chemistry, 280:7253-61
Chen, Z., Singer, W.D., Sternweis, P.C. and Sprang, S. R. “Structure of the p115rhoGEF rgRGS domain of-Ga1/i1 chimera complex suggests convergent evolution of a GTPase activator “ (2005), Nature Structural and Molecular Biology, 12:191-7
Sinha, S.C., Wetter, M., Schultz, Sprang, S. and Linder, J (2005) “Asymmetry in Homodimeric Adenylyl Cyclases: Structures of the Mycobacterium tuberculosis Rv 1900c” EMBO Journal, 24:663-73
Davis, T., Bonacci, T.M., Smrcka, AV. and Sprang, S.R. (2005) “Structural and Molecular Characterization of a Preferred Protein Interaction Surface on G Protein bg Subunits” (2005) Biochemistry 44:10593-10604
Ja, W.W., Adhikari, A., Austin, R.J., Sprang, S.R., Roberts, R.W.(2005) “A peptide core motif for binding to heterotrimeric G protein a subunits” Journal of Biological Chemistry, 280:32057-32060
Mou, T-C, Gille, A., Suryanarayana, S.,Richter, M., Seifert, R. and Sprang, S.R.(2006) “Broad Specificity of Mammalian Adenylyl Cyclases for Interaction with 2’,3’-Substituted Purine-and Pyrimidine Nucleotide Inhibitors” Molecular Pharmacology,70:878-886
Sinha, S.C. and Sprang, S. (2006) “Structures, mechanism, regulation and evolution of class III nucleotidyl cyclases” Reviews of Physiology, Biochemistry and Pharmacology 157:105-140
Sprang, S.R., Chen, Z and Du, X. (2007)“Structural basis of effector regulation and signal termination in heterotrimeric Ga proteins” Advances Prot. Chem. 74:1-65
Du, X., Ferguson, K., Gregory, R. and Sprang, S.R. (2008) “A method to determine 18O kinetic isotope effects in the hydrolysis of nucleotide triphosphates” Analytical Biochemistry 372:213-21
Sprang, S. (2007) “A Receptor Unlocked”, Nature, 450, 355-6